ANNA BROOKS: Open Payments
NPI 1891166450 · MARTINEZ, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 13 payments from 7 companies in 2025. Trend: 2023 $387 · 2024 $346 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $115 |
| Novartis Pharmaceuticals Corporation | 1 | $53 |
| Lilly USA, LLC | 2 | $35 |
| ABBVIE INC. | 1 | $26 |
| Indivior Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: REPATHA, LEQVIO, MOUNJARO, VRAYLAR, SUBLOCADE, CAPLYTA, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
